A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT02425137 · COMPLETED
Trial details
- NCT number
- NCT02425137
- Sponsor
- TTY Biopharm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-05-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.